125 related articles for article (PubMed ID: 10843525)
21. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies.
Fiore JR; Suligoi B; Saracino A; Di Stefano M; Bugarini R; Lepera A; Favia A; Monno L; Angarano G; Pastore G
AIDS; 2003 Oct; 17(15):2169-76. PubMed ID: 14523273
[TBL] [Abstract][Full Text] [Related]
22. Plasma and mucosal HIV viral loads are associated with genital tract inflammation in HIV-infected women.
Herold BC; Keller MJ; Shi Q; Hoover DR; Carpenter CA; Huber A; Parikh UM; Agnew KJ; Minkoff H; Colie C; Nowicki MJ; DʼSouza G; Watts DH; Anastos K
J Acquir Immune Defic Syndr; 2013 Aug; 63(4):485-93. PubMed ID: 23591635
[TBL] [Abstract][Full Text] [Related]
23. Female genital tract shedding of HIV-1 is rare in women with suppressed HIV-1 in plasma.
Nelson JAE; De Paris K; Ramirez C; Edmonds A; Mollan KR; Bay CP; Compliment K; Herold BC; Anastos K; Minkoff H; Kassaye S; Seidman DL; French AL; Golub ET; Sheth AN; Ochsenbauer C; Swanstrom R; Eron JJ; Adimora AA
AIDS; 2020 Jan; 34(1):39-46. PubMed ID: 31483374
[TBL] [Abstract][Full Text] [Related]
24. Relationship Between Genital Drug Concentrations and Cervical Cellular Immune Activation and Reconstitution in HIV-1-Infected Women on a Raltegravir Versus a Boosted Atazanavir Regimen.
Meditz AL; Palmer C; Predhomme J; Searls K; Kerr B; Seifert S; Caraway P; Gardner EM; MaWhinney S; Anderson PL
AIDS Res Hum Retroviruses; 2015 Oct; 31(10):1015-22. PubMed ID: 26059647
[TBL] [Abstract][Full Text] [Related]
25. Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women.
Coombs RW; Wright DJ; Reichelderfer PS; Burns DN; Cohn J; Cu-Uvin S; Baron PA; Cohen MH; Landay AL; Lewis S; Kovacs A;
J Infect Dis; 2001 Nov; 184(9):1187-91. PubMed ID: 11598843
[TBL] [Abstract][Full Text] [Related]
26. Directly observed antiretroviral therapy to reduce genital tract and plasma HIV-1 RNA in women with poor adherence.
Harwell JI; Flanigan TP; Mitty JA; Macalino GE; Caliendo AM; Ingersoll J; Stenzel MS; Carpenter CC; Cu-Uvin S
AIDS; 2003 Sep; 17(13):1990-3. PubMed ID: 12960835
[TBL] [Abstract][Full Text] [Related]
27. Metagenomic Sequencing of HIV-1 in the Blood and Female Genital Tract Reveals Little Quasispecies Diversity during Acute Infection.
Piantadosi A; Freije CA; Gosmann C; Ye S; Park D; Schaffner SF; Tully DC; Allen TM; Dong KL; Sabeti PC; Kwon DS
J Virol; 2019 Jan; 93(2):. PubMed ID: 30381486
[TBL] [Abstract][Full Text] [Related]
28. Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota.
Mitchell C; Hitti J; Paul K; Agnew K; Cohn SE; Luque AE; Coombs R
AIDS Res Hum Retroviruses; 2011 Jan; 27(1):35-9. PubMed ID: 20929397
[TBL] [Abstract][Full Text] [Related]
29. Association of High-Risk Human Papillomavirus with Genital Tract Mucosal Immune Factors in HIV-Infected Women.
Buckley N; Huber A; Lo Y; Castle PE; Kemal K; Burk RD; Strickler HD; Einstein MH; Young M; Anastos K; Herold BC
Am J Reprod Immunol; 2016 Feb; 75(2):146-54. PubMed ID: 26685115
[TBL] [Abstract][Full Text] [Related]
30. Evidence of genetic variability of human immunodeficiency virus type 1 in plasma and cervicovaginal lavage in ethiopian women seeking care for sexually transmitted infections.
Adal M; Ayele W; Wolday D; Dagne K; Messele T; Tilahun T; Berkhout B; Mayaan S; Pollakis G; Dorigo-Zetsma W
AIDS Res Hum Retroviruses; 2005 Jul; 21(7):649-53. PubMed ID: 16060836
[TBL] [Abstract][Full Text] [Related]
31. Lack of association between human immunodeficiency virus type 1 antibody in cervicovaginal lavage fluid and plasma and perinatal transmission, in Thailand.
Chuachoowong R; Shaffer N; VanCott TC; Chaisilwattana P; Siriwasin W; Waranawat N; Vanprapar N; Young NL; Mastro TD; Lambert JS; Robb ML
J Infect Dis; 2000 Jun; 181(6):1957-63. PubMed ID: 10837175
[TBL] [Abstract][Full Text] [Related]
32. Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding.
Fiore JR; Laddago V; Lepera A; La Grasta L; Di Stefano M; Saracino A; Lopalco P; Pastore G; Angarano G
New Microbiol; 2000 Jan; 23(1):85-92. PubMed ID: 10946410
[TBL] [Abstract][Full Text] [Related]
33. The effect of vaginal candidiasis on the shedding of human immunodeficiency virus in cervicovaginal secretions.
Spinillo A; Zara F; Gardella B; Preti E; Mainini R; Maserati R
Am J Obstet Gynecol; 2005 Mar; 192(3):774-9. PubMed ID: 15746671
[TBL] [Abstract][Full Text] [Related]
34. Differences in HIV-1 pol sequences from female genital tract and blood during antiretroviral therapy.
De Pasquale MP; Leigh Brown AJ; Uvin SC; Allega-Ingersoll J; Caliendo AM; Sutton L; Donahue S; D'Aquila RT
J Acquir Immune Defic Syndr; 2003 Sep; 34(1):37-44. PubMed ID: 14501791
[TBL] [Abstract][Full Text] [Related]
35. Impact of etonogestrel implant use on T-cell and cytokine profiles in the female genital tract and blood.
Haddad LB; Swaims-Kohlmeier A; Mehta CC; Haaland RE; Brown NL; Sheth AN; Chien H; Titanji K; Achilles SL; Lupo D; Hart CE; Ofotokun I
PLoS One; 2020; 15(3):e0230473. PubMed ID: 32214321
[TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus type 1-related nucleic acids and papillomavirus DNA in cervicovaginal secretions of immunodeficiency virus-infected women.
Spinillo A; Debiaggi M; Zara F; De Santolo A; Polatti F; Filice G
Obstet Gynecol; 2001 Jun; 97(6):999-1004. PubMed ID: 11384710
[TBL] [Abstract][Full Text] [Related]
37. Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage.
Archary D; Liebenberg LJ; Werner L; Tulsi S; Majola N; Naicker N; Dlamini S; Hope TJ; Samsunder N; Abdool Karim SS; Morris L; Passmore JA; Garrett NJ
PLoS One; 2015; 10(7):e0131906. PubMed ID: 26147923
[TBL] [Abstract][Full Text] [Related]
38. Positive association between HIV RNA and IL-6 in the genital tract of Rwandan women.
Spear GT; Zariffard MR; Chen HY; Anzinger JJ; Anastos K; Rusine J; Gatabazi J; French AL; Cohen M; Landay AL
AIDS Res Hum Retroviruses; 2008 Jul; 24(7):973-6. PubMed ID: 18671479
[TBL] [Abstract][Full Text] [Related]
39. HIV-inducing factor in cervicovaginal secretions is associated with bacterial vaginosis in HIV-1-infected women.
Cohn JA; Hashemi FB; Camarca M; Kong F; Xu J; Beckner SK; Kovacs AA; Reichelderfer PS; Spear GT
J Acquir Immune Defic Syndr; 2005 Jul; 39(3):340-6. PubMed ID: 15980696
[TBL] [Abstract][Full Text] [Related]
40. Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. Bangkok Collaborative Perinatal HIV Transmission Study Group.
Chuachoowong R; Shaffer N; Siriwasin W; Chaisilwattana P; Young NL; Mock PA; Chearskul S; Waranawat N; Chaowanachan T; Karon J; Simonds RJ; Mastro TD
J Infect Dis; 2000 Jan; 181(1):99-106. PubMed ID: 10608756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
